Literature DB >> 12369089

Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.

Neelu Kaila1, Bert E Thomas.   

Abstract

The selectins are a family of cell-adhesion proteins that mediate the rolling of leukocytes on activated endothelial cells through the recognition of the carbohydrate epitope sialyl Lewis(x) (sLe(x)). Control of the leukocyte-endothelial cell adhesion process may prove useful in cases where excess recruitment of leukocytes can contribute to acute diseases such as stroke and reperfusion injury and chronic diseases such as psoriasis and rheumatoid arthritis. The development of molecules that block the interactions between sLe(x) and the selectins has become an active area of research. In this review, we will highlight the various approaches taken toward the development of sLe(x) mimetics as antagonists of E- and P-selectin, including the use of structural information about the selectins and their interactions with sLe(x) that have been revealed through the use of NMR, protein crystallography and molecular modeling. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369089     DOI: 10.1002/med.10018

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  25 in total

1.  Sticky wickets in lower nephron nephrosis.

Authors:  Friedrich C Luft
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

2.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

3.  Chemoenzymatic synthesis of α2-3-sialylated carbohydrate epitopes.

Authors:  Huang Shengshu; Yu Hai; Chen Xi
Journal:  Sci China Chem       Date:  2011-01       Impact factor: 9.445

4.  A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists.

Authors:  Mickael Calosso; Daniel Charpentier; Marc Vaillancourt; Mohammed Bencheqroun; Gabrielle St-Pierre; Brian C Wilkes; Yvan Guindon
Journal:  ACS Med Chem Lett       Date:  2012-10-11       Impact factor: 4.345

5.  Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study.

Authors:  Pavel Šmak; Selvaraj Chandrabose; Igor Tvaroška; Jaroslav Koča
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

6.  New sialyl Lewis(x) mimic containing an alpha-substituted beta(3)-amino acid spacer.

Authors:  Silvana Pedatella; Mauro De Nisco; Beat Ernst; Annalisa Guaragna; Beatrice Wagner; Robert J Woods; Giovanni Palumbo
Journal:  Carbohydr Res       Date:  2007-10-07       Impact factor: 2.104

7.  Expression, purification, and refolding of active recombinant human E-selectin lectin and EGF domains in Escherichia coli.

Authors:  Susumu Kawano; Daisuke Iyaguchi; Chiaki Okada; Yusuke Sasaki; Eiko Toyota
Journal:  Protein J       Date:  2013-06       Impact factor: 2.371

8.  Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease.

Authors:  Alison E John; Nicholas W Lukacs; Aaron A Berlin; Aiyappa Palecanda; Robert F Bargatze; Lloyd M Stoolman; Jon O Nagy
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

9.  Covalent immobilization of p-selectin enhances cell rolling.

Authors:  Seungpyo Hong; Dooyoung Lee; Huanan Zhang; Jennifer Q Zhang; Jennifer N Resvick; Ali Khademhosseini; Michael R King; Robert Langer; Jeffrey M Karp
Journal:  Langmuir       Date:  2007-10-20       Impact factor: 3.882

10.  Chemical preparation of sialyl Lewis x using an enzymatically synthesized sialoside building block.

Authors:  Hongzhi Cao; Shengshu Huang; Jiansong Cheng; Yanhong Li; Saddam Muthana; Bryan Son; Xi Chen
Journal:  Carbohydr Res       Date:  2008-07-04       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.